Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies.

Détails

ID Serval
serval:BIB_8F6FE32931A7
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies.
Périodique
Cell reports
Auteur⸱e⸱s
Schmidt F.I., Bleck C.K., Reh L., Novy K., Wollscheid B., Helenius A., Stahlberg H., Mercer J.
ISSN
2211-1247 (Electronic)
Statut éditorial
Publié
Date de publication
15/08/2013
Peer-reviewed
Oui
Volume
4
Numéro
3
Pages
464-476
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Host cell entry of vaccinia virus, the prototypic poxvirus, involves a membrane fusion event delivering the viral core and two proteinaceous lateral bodies (LBs) into the cytosol. Uncoating of viral cores is poorly characterized, and the composition and function of LBs remains enigmatic. We found that cytosolic cores rapidly dissociated from LBs and expanded in volume, which coincided with reduction of disulfide-bonded core proteins. We identified the abundant phosphoprotein F17, the dual-specificity phosphatase VH1, and the oxidoreductase G4 as bona fide LB components. After reaching the cytosol, F17 was degraded in a proteasome-dependent manner. Proteasome activity, and presumably LB disassembly, was required for the immediate immunomodulatory activity of VH1: dephosphorylation of STAT1 to prevent interferon-γ-mediated antiviral responses. These results reveal a mechanism used by poxviruses to deliver viral enzymes to the host cell cytosol and are likely to facilitate the identification of additional LB-resident viral effectors.
Mots-clé
Animals, Cell Line, Chlorocebus aethiops, Dual-Specificity Phosphatases/metabolism, HeLa Cells, Humans, Proteasome Endopeptidase Complex/metabolism, STAT1 Transcription Factor/metabolism, Signal Transduction, Vaccinia/enzymology, Vaccinia/metabolism, Vaccinia/virology, Vaccinia virus/enzymology, Vaccinia virus/metabolism, Vaccinia virus/physiology, Viral Proteins/metabolism, Virus Activation
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/06/2023 15:03
Dernière modification de la notice
20/07/2023 5:57
Données d'usage